Impact of estimated glomerular filtration rate based on plasma cystatin C and serum creatinine levels before allogeneic hematopoietic cell transplantation

Hidenori Wada, Junya Kanda, Yu Akahoshi, Hirofumi Nakano, Tomotaka Ugai, Ryoko Yamasaki, Yuko Ishihara, Koji Kawamura, Kana Sakamoto, Masahiro Ashizawa, Miki Sato, Kiriko Terasako-Saito, Shun ichi Kimura, Misato Kikuchi, Hideki Nakasone, Rie Yamazaki, Shinichi Kako, Aki Tanihara, Junji Nishida, Yoshinobu Kanda

Research output: Contribution to journalArticle

Abstract

Background: No standard method for measuring renal function has been established in allogeneic hematopoietic cell transplantation (allo-HCT). Methods: We retrospectively analyzed 80 patients with hematological diseases who underwent allo-HCT at our center. We assessed renal function using creatinine clearance (Ccr), estimated glomerular filtration rate (eGFR) based on creatinine (eGFRcre), eGFR based on cystatin C (eGFRcys), and the average of eGFRcre and eGFRcys (eGFRave). We then evaluated the impact of pre-transplant renal function on the exacerbation of renal function and non-relapse mortality after transplantation. Results: There was a significant correlation between Ccr and eGFRcre, eGFRcys, and eGFRave. eGFRave best predicted the exacerbation of renal function according to the area under the receiver-operating characteristic curve. The cumulative incidence of renal function exacerbation at 1 year was higher in the lower eGFRave group (<90 ml/min/1.73 m2) than in the higher eGFRave group (≥90 ml/min/1.73 m2; 0.85 vs. 0.39, p < 0.001), which was confirmed by a multivariate analysis (HR 2.75, p = 0.001). A lower eGFRave value was a marginally significant factor for non-relapse mortality (HR 3.29, p = 0.076). Conclusion: Among the four parameters, eGFRave best predicted the exacerbation of renal function in allo-HCT. Further, the marginal association between low eGFRave and high non-relapse mortality warrants further study in a prospective study in allo-HCT.

Original languageEnglish
Pages (from-to)271-276
Number of pages6
JournalHematology
Volume23
Issue number5
DOIs
Publication statusPublished - 2018 May 28
Externally publishedYes

Fingerprint

Cystatin C
Cell Transplantation
Glomerular Filtration Rate
Creatinine
Kidney
Serum
Mortality
Hematologic Diseases
ROC Curve
Multivariate Analysis
Transplantation
Prospective Studies
Transplants
Incidence

Keywords

  • Allogeneic transplantation
  • creatinine clearance
  • cystatin C
  • estimated glomerular filtration rate

ASJC Scopus subject areas

  • Hematology

Cite this

Impact of estimated glomerular filtration rate based on plasma cystatin C and serum creatinine levels before allogeneic hematopoietic cell transplantation. / Wada, Hidenori; Kanda, Junya; Akahoshi, Yu; Nakano, Hirofumi; Ugai, Tomotaka; Yamasaki, Ryoko; Ishihara, Yuko; Kawamura, Koji; Sakamoto, Kana; Ashizawa, Masahiro; Sato, Miki; Terasako-Saito, Kiriko; Kimura, Shun ichi; Kikuchi, Misato; Nakasone, Hideki; Yamazaki, Rie; Kako, Shinichi; Tanihara, Aki; Nishida, Junji; Kanda, Yoshinobu.

In: Hematology, Vol. 23, No. 5, 28.05.2018, p. 271-276.

Research output: Contribution to journalArticle

Wada, H, Kanda, J, Akahoshi, Y, Nakano, H, Ugai, T, Yamasaki, R, Ishihara, Y, Kawamura, K, Sakamoto, K, Ashizawa, M, Sato, M, Terasako-Saito, K, Kimura, SI, Kikuchi, M, Nakasone, H, Yamazaki, R, Kako, S, Tanihara, A, Nishida, J & Kanda, Y 2018, 'Impact of estimated glomerular filtration rate based on plasma cystatin C and serum creatinine levels before allogeneic hematopoietic cell transplantation', Hematology, vol. 23, no. 5, pp. 271-276. https://doi.org/10.1080/10245332.2017.1396026
Wada, Hidenori ; Kanda, Junya ; Akahoshi, Yu ; Nakano, Hirofumi ; Ugai, Tomotaka ; Yamasaki, Ryoko ; Ishihara, Yuko ; Kawamura, Koji ; Sakamoto, Kana ; Ashizawa, Masahiro ; Sato, Miki ; Terasako-Saito, Kiriko ; Kimura, Shun ichi ; Kikuchi, Misato ; Nakasone, Hideki ; Yamazaki, Rie ; Kako, Shinichi ; Tanihara, Aki ; Nishida, Junji ; Kanda, Yoshinobu. / Impact of estimated glomerular filtration rate based on plasma cystatin C and serum creatinine levels before allogeneic hematopoietic cell transplantation. In: Hematology. 2018 ; Vol. 23, No. 5. pp. 271-276.
@article{6e5f21983f8e41e5809fdc24126d10b9,
title = "Impact of estimated glomerular filtration rate based on plasma cystatin C and serum creatinine levels before allogeneic hematopoietic cell transplantation",
abstract = "Background: No standard method for measuring renal function has been established in allogeneic hematopoietic cell transplantation (allo-HCT). Methods: We retrospectively analyzed 80 patients with hematological diseases who underwent allo-HCT at our center. We assessed renal function using creatinine clearance (Ccr), estimated glomerular filtration rate (eGFR) based on creatinine (eGFRcre), eGFR based on cystatin C (eGFRcys), and the average of eGFRcre and eGFRcys (eGFRave). We then evaluated the impact of pre-transplant renal function on the exacerbation of renal function and non-relapse mortality after transplantation. Results: There was a significant correlation between Ccr and eGFRcre, eGFRcys, and eGFRave. eGFRave best predicted the exacerbation of renal function according to the area under the receiver-operating characteristic curve. The cumulative incidence of renal function exacerbation at 1 year was higher in the lower eGFRave group (<90 ml/min/1.73 m2) than in the higher eGFRave group (≥90 ml/min/1.73 m2; 0.85 vs. 0.39, p < 0.001), which was confirmed by a multivariate analysis (HR 2.75, p = 0.001). A lower eGFRave value was a marginally significant factor for non-relapse mortality (HR 3.29, p = 0.076). Conclusion: Among the four parameters, eGFRave best predicted the exacerbation of renal function in allo-HCT. Further, the marginal association between low eGFRave and high non-relapse mortality warrants further study in a prospective study in allo-HCT.",
keywords = "Allogeneic transplantation, creatinine clearance, cystatin C, estimated glomerular filtration rate",
author = "Hidenori Wada and Junya Kanda and Yu Akahoshi and Hirofumi Nakano and Tomotaka Ugai and Ryoko Yamasaki and Yuko Ishihara and Koji Kawamura and Kana Sakamoto and Masahiro Ashizawa and Miki Sato and Kiriko Terasako-Saito and Kimura, {Shun ichi} and Misato Kikuchi and Hideki Nakasone and Rie Yamazaki and Shinichi Kako and Aki Tanihara and Junji Nishida and Yoshinobu Kanda",
year = "2018",
month = "5",
day = "28",
doi = "10.1080/10245332.2017.1396026",
language = "English",
volume = "23",
pages = "271--276",
journal = "Hematology",
issn = "1024-5332",
publisher = "Taylor and Francis Ltd.",
number = "5",

}

TY - JOUR

T1 - Impact of estimated glomerular filtration rate based on plasma cystatin C and serum creatinine levels before allogeneic hematopoietic cell transplantation

AU - Wada, Hidenori

AU - Kanda, Junya

AU - Akahoshi, Yu

AU - Nakano, Hirofumi

AU - Ugai, Tomotaka

AU - Yamasaki, Ryoko

AU - Ishihara, Yuko

AU - Kawamura, Koji

AU - Sakamoto, Kana

AU - Ashizawa, Masahiro

AU - Sato, Miki

AU - Terasako-Saito, Kiriko

AU - Kimura, Shun ichi

AU - Kikuchi, Misato

AU - Nakasone, Hideki

AU - Yamazaki, Rie

AU - Kako, Shinichi

AU - Tanihara, Aki

AU - Nishida, Junji

AU - Kanda, Yoshinobu

PY - 2018/5/28

Y1 - 2018/5/28

N2 - Background: No standard method for measuring renal function has been established in allogeneic hematopoietic cell transplantation (allo-HCT). Methods: We retrospectively analyzed 80 patients with hematological diseases who underwent allo-HCT at our center. We assessed renal function using creatinine clearance (Ccr), estimated glomerular filtration rate (eGFR) based on creatinine (eGFRcre), eGFR based on cystatin C (eGFRcys), and the average of eGFRcre and eGFRcys (eGFRave). We then evaluated the impact of pre-transplant renal function on the exacerbation of renal function and non-relapse mortality after transplantation. Results: There was a significant correlation between Ccr and eGFRcre, eGFRcys, and eGFRave. eGFRave best predicted the exacerbation of renal function according to the area under the receiver-operating characteristic curve. The cumulative incidence of renal function exacerbation at 1 year was higher in the lower eGFRave group (<90 ml/min/1.73 m2) than in the higher eGFRave group (≥90 ml/min/1.73 m2; 0.85 vs. 0.39, p < 0.001), which was confirmed by a multivariate analysis (HR 2.75, p = 0.001). A lower eGFRave value was a marginally significant factor for non-relapse mortality (HR 3.29, p = 0.076). Conclusion: Among the four parameters, eGFRave best predicted the exacerbation of renal function in allo-HCT. Further, the marginal association between low eGFRave and high non-relapse mortality warrants further study in a prospective study in allo-HCT.

AB - Background: No standard method for measuring renal function has been established in allogeneic hematopoietic cell transplantation (allo-HCT). Methods: We retrospectively analyzed 80 patients with hematological diseases who underwent allo-HCT at our center. We assessed renal function using creatinine clearance (Ccr), estimated glomerular filtration rate (eGFR) based on creatinine (eGFRcre), eGFR based on cystatin C (eGFRcys), and the average of eGFRcre and eGFRcys (eGFRave). We then evaluated the impact of pre-transplant renal function on the exacerbation of renal function and non-relapse mortality after transplantation. Results: There was a significant correlation between Ccr and eGFRcre, eGFRcys, and eGFRave. eGFRave best predicted the exacerbation of renal function according to the area under the receiver-operating characteristic curve. The cumulative incidence of renal function exacerbation at 1 year was higher in the lower eGFRave group (<90 ml/min/1.73 m2) than in the higher eGFRave group (≥90 ml/min/1.73 m2; 0.85 vs. 0.39, p < 0.001), which was confirmed by a multivariate analysis (HR 2.75, p = 0.001). A lower eGFRave value was a marginally significant factor for non-relapse mortality (HR 3.29, p = 0.076). Conclusion: Among the four parameters, eGFRave best predicted the exacerbation of renal function in allo-HCT. Further, the marginal association between low eGFRave and high non-relapse mortality warrants further study in a prospective study in allo-HCT.

KW - Allogeneic transplantation

KW - creatinine clearance

KW - cystatin C

KW - estimated glomerular filtration rate

UR - http://www.scopus.com/inward/record.url?scp=85032708071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032708071&partnerID=8YFLogxK

U2 - 10.1080/10245332.2017.1396026

DO - 10.1080/10245332.2017.1396026

M3 - Article

C2 - 29086660

AN - SCOPUS:85032708071

VL - 23

SP - 271

EP - 276

JO - Hematology

JF - Hematology

SN - 1024-5332

IS - 5

ER -